ESC 365 - An atrial fibrillation patient needing combination antiarrhythmic drug treatment - What do the Guidelines say?

ESC Premium Access

An atrial fibrillation patient needing combination antiarrhythmic drug treatment - What do the Guidelines say?

Session: Atrial fibrillation: from Guidelines to clinical practice

Topic: Atrial Fibrillation (AF)

Speaker: Professor P. Kirchhof (Hamburg, DE)

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Professor Paulus Kirchhof

University Heart and Vascular Centre Hamburg (UHZ), Hamburg (Germany)

61 presentations

8 followers

7 more presentations in this session

Case 1: an atrial fibrillation patient needing combination antiarrhythmic drug treatment

Speaker: Professor G. Dan (Bucharest, RO)

An atrial fibrillation patient needing combination antiarrhythmic drug treatment - How to implement the Guidelines.

An atrial fibrillation patient needing combination antiarrhythmic drug treatment - Conclusion and take home message.

Speaker: Professor N. Marrouche (New Orleans, US)

Case 2: an atrial fibrillation patient with high CHA2DS2-VASc Score, a gastrointestinal bleed and renal impairment

Speaker: Doctor M. Akao (Kyoto, JP)

An atrial fibrillation patient with high CHA2DS2-VASc Score, a gastrointestinal bleed and renal impairment - What do the Guidelines say?

Speaker: Professor M. Taborsky (Olomouc, CZ)

Access the full session

Atrial fibrillation: from Guidelines to clinical practice

Speakers: Professor P. Kirchhof, Professor G. Dan, Professor N. Marrouche, Doctor M. Akao, Professor M. Taborsky

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources